-
MRI effective in detecting postpartum breast cancers
europeanpharmaceuticalreview
May 06, 2019
Pregnancy-associated breast cancer, which is rare but often aggressive, has been detected with MRI…
-
ALA-artemisinin combination therapy for cancer identified
europeanpharmaceuticalreview
May 06, 2019
Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment…
-
TK216-vincristine combination for Ewing sarcoma identified
europeanpharmaceuticalreview
May 06, 2019
TK216-vincristine combination appears to halt the ability of Ewing sarcoma to grow and progress…
-
PI3K inhibitors show hope for rare bone cancers
europeanpharmaceuticalreview
May 06, 2019
Scientists have used genome sequencing to gain a better understanding of the biology underlying chordoma…
-
Neratinib defeats the Ras genes notorious for causing cancer
europeanpharmaceuticalreview
May 06, 2019
Breast cancer drug neratinib has been found to block the function of the Ras genes which are among the first to be linked to cancer development…
-
AUA: Atenolol Linked to Drop in Low-, Intermediate-Risk Prostate Cancer
drugs
May 06, 2019
Atenolol is associated with a reduction in incident intermediate- and low-risk prostate cancer (PCa)...
-
Cardio-Oncology Services Growing in Number and Demand
drugs
May 06, 2019
Cardio-Oncology Services Growing in Number and Demand...
-
Does Hormone Therapy for Prostate Cancer Raise Dementia Risk?
drugs
May 06, 2019
Does Hormone Therapy for Prostate Cancer Raise Dementia Risk?
-
Antimalarial drugs could support existing cancer treatments
europeanpharmaceuticalreview
May 05, 2019
Chloroquine and hydroxychloroquine could make cancer treatments more effective…
-
PAC-1-temozolomide combination shows promise for anaplastic astrocytoma
europeanpharmaceuticalreview
May 05, 2019
A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma…